A Study of CIN-107 in Adults with Primary Aldosteronism

Trial Identifier: CIN-107-122
Sponsor: AstraZeneca
Start Date: March 2021
Primary Completion Date: October 2024
Study Completion Date: October 2024

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description
English Version

Trial Locations

Country Location
US, CA San Francisco, CA, US, 94110
US, CA West Hollywood, CA, US, 90048
US, IL Chicago, IL, US, 60611
US, MD Baltimore, MD, US, 21287
US, MI Ann Arbor, MI, US, 48109
US, MN Rochester, MN, US, 55905
US, OH Cincinnati, OH, US, 45245
US, OH Columbus, OH, US, 43210
US, TX Dallas, TX, US, 75390-9047